Effect of neuromuscular electrical stimulation in patients with sepsis

Not Applicable

• Conditions: Sepsis

• Registration Number: JPRN-UMIN000028864
• Lead Sponsor: agoya University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-10-01
• Study Completion: 2020-02-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1. Unable to walk without assistance before ICU admission 2. Neuromuscular disease (e.g. myasthenia Gravis, Guillain-Barre disease) 3. Muscle inflammation (e.g. rhabdomyolysis, myositis, neuroleptic malignant syndrome) 4. Skin lesions (e.g. burns) 5. Patients who were determined inappropriate to rehabilitation because of declining clinical status. 6. Patients who were determined inappropriate to participate in this study by attending physician.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main outcome is the mobility ability. The measurement is performed at ICU admission and discharge, and before hospital discharge. Difference in the mobility ability between patients with neuromuscular electrical stimulation and those without historical control.

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is the muscle strength and activity of daily living. The measurement is performed at ICU admission and discharge, and before hospital discharge. Difference in the muscle strength and activity of daily living between patients with neuromuscular electrical stimulation and those without historical control.